Alexandra Borodovsky

Author

AstraZeneca (United States)

Also Known As

A. Borodovsky, Alexandra Borodovsky

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United States)Johns Hopkins Medicine Johns Hopkins University Memorial Sloan Kettering Cancer Center AstraZeneca (United Kingdom)

About

Alexandra Borodovsky is an author at AstraZeneca (United States) specializing in tumor biology, medicine, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	692
2	Cell Biology	6	6	652
3	Health Sciences	1	1	153
4	Natural Sciences	1	1	27
5	Biomolecular Engineering	1	1	27

Alexandra Borodovsky

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists James Kim, Blake T. Aftab, Jean Y. Tang, Cancer Cell Smoothened AntagonistsChemoprevention StrategyAcquired ResistanceMedicineTumor Growth Associated	2013	329
Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine Şevin Turcan, Armida W. M. Fabius, Alexandra Borodovsky, Oncotarget	2013	233
5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft Alexandra Borodovsky, Vafi Salmasi, Şevin Turcan, Oncotarget 5-Azacytidine Reduces MethylationHigh-grade GliomasCancer BiologyGliomaTumor Biology	2013	153
Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade Rui Yang, Samah Elsaadi, Kristine Misund, Journal for ImmunoTherapy of Cancer	2020	114
Repurposing the Antihelmintic Mebendazole as a Hedgehog Inhibitor Andrew R. Larsen, Ren-Yuan Bai, Jon Chung, Molecular Cancer Therapeutics Nematode TubulinChemoprevention StrategyAntiparasitic AgentPathologyPrimary Cilium	2014	101
Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic Response Ben Sidders, Pei Zhang, Kelly Goodwin, Clinical Cancer Research	2020	96
Small molecule AZD4635 inhibitor of A<sub>2A</sub>R signaling rescues immune cell function including CD103<sup>+</sup> dendritic cells enhancing anti-tumor immunity Alexandra Borodovsky, Christine M. Barbon, Yanjun Wang, Journal for ImmunoTherapy of Cancer	2020	96
Demethylation and epigenetic modification with 5-azacytidine reduces IDH1 mutant glioma growth in combination with temozolomide Alex Shimura Yamashita, Marina da Costa Rosa, Alexandra Borodovsky, Neuro-Oncology	2018	68
Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patients Avadhut D. Joshi, Rachel C. Botham, Lisa J. Schlein, Oncotarget	2017	46
Development of a quantification method for adenosine in tumors by LC-MS/MS with dansyl chloride derivatization Kelly Goodwin, Eric T. Gangl, Ujjal Sarkar, Analytical Biochemistry Quantification MethodOncologyMedicineBioanalysisDansyl Chloride Derivatization	2018	28

Page 1